Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDARUBICIN vs IDELALISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDARUBICIN vs IDELALISIB: Safety Overview

Metric IDARUBICIN IDELALISIB
Total FAERS Reports 5,038 6,862
Deaths Reported 1,260 1,548
Death Rate 25.0% 22.6%
Hospitalizations 1,856 2,962
Average Patient Age 44.8 yrs 70.0 yrs
% Female Patients 46.2% 38.4%
FDA Approval Date Apr 25, 1995 Jul 23, 2014
Manufacturer Pfizer Laboratories Div Pfizer Inc Gilead Sciences, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription